Managed Account Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Managed Account Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,420	Closed	-$66K	–	3145
2015 Q1	$66K	Sell	3,420 -70,272	-95%	-$1.3M	﹤0.01%	2584
2014 Q4	$1.21M	Sell	73,692 -93,506	-56%	-$1.6M	﹤0.01%	2010
2014 Q3	$2.96M	Sell	167,198 -2,087	-1%	-$41K	﹤0.01%	1639
2014 Q2	$3.49M	Sell	169,285 -12,148	-7%	-$250K	﹤0.01%	1542
2014 Q1	$3.95M	Sell	181,433 -940	-0.5%	-$21.5K	0.01%	1431
2013 Q4	$4.84M	Sell	182,373 -18,258	-9%	-$449K	0.01%	1312
2013 Q3	$4.74M	Sell	200,631 -43,275	-18%	-$1.01M	0.01%	1257
2013 Q2	$5.24M	Buy	+243,906	New	+$5.26M	0.01%	1180

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's VIVO Position: Q2 2015 in Review

Managed Account Advisors sold out of Meridian Bioscience Inc (VIVO) in Q2 2015, closing a stake of 3,420 shares — an estimated $66K sold.

Managed Account Advisors first reported a position in VIVO in Q2 2013 and held it in 8 quarters. The position peaked at $5.24M in Q2 2013. 168 funds tracked by Wall St. Rank hold VIVO as of Q2 2015.

Managed Account Advisors reported no remaining Meridian Bioscience Inc position as of Q2 2015 after selling out during the quarter.
Managed Account Advisors sold 3,420 Meridian Bioscience Inc shares in Q2 2015, an estimated $66K.
Managed Account Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 8 quarters.
Managed Account Advisors's Meridian Bioscience Inc position peaked at $5.24M in Q2 2013.
168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.